189 related articles for article (PubMed ID: 38480740)
1. Thermophoretic glycan profiling of extracellular vesicles for triple-negative breast cancer management.
Li Y; Zhang S; Liu C; Deng J; Tian F; Feng Q; Qin L; Bai L; Fu T; Zhang L; Wang Y; Sun J
Nat Commun; 2024 Mar; 15(1):2292. PubMed ID: 38480740
[TBL] [Abstract][Full Text] [Related]
2. N-Linked glycosylation profiles of therapeutic induced senescent (TIS) triple negative breast cancer cells (TNBC) and their extracellular vesicle (EV) progeny.
Kavanagh EL; Halasz M; Dowling P; Withers J; Lindsay S; Higgins MJ; Irwin JA; Rudd PM; Saldova R; McCann A
Mol Omics; 2021 Feb; 17(1):72-85. PubMed ID: 33325943
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Jung HH; Kim JY; Cho EY; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958571
[TBL] [Abstract][Full Text] [Related]
5. One-Step Thermophoretic AND Gate Operation on Extracellular Vesicles Improves Diagnosis of Prostate Cancer.
Deng J; Zhao S; Li J; Cheng Y; Liu C; Liu Z; Li L; Tian F; Dai B; Sun J
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202207037. PubMed ID: 35749531
[TBL] [Abstract][Full Text] [Related]
6. PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
Absmaier M; Napieralski R; Schuster T; Aubele M; Walch A; Magdolen V; Dorn J; Gross E; Harbeck N; Noske A; Kiechle M; Schmitt M
Int J Oncol; 2018 Mar; 52(3):755-767. PubMed ID: 29328369
[TBL] [Abstract][Full Text] [Related]
7. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
[TBL] [Abstract][Full Text] [Related]
8. Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer.
Tian F; Zhang S; Liu C; Han Z; Liu Y; Deng J; Li Y; Wu X; Cai L; Qin L; Chen Q; Yuan Y; Liu Y; Cong Y; Ding B; Jiang Z; Sun J
Nat Commun; 2021 May; 12(1):2536. PubMed ID: 33953198
[TBL] [Abstract][Full Text] [Related]
9. High-throughput analysis of glycan sorting into extracellular vesicles.
Pendiuk Goncalves J; Cruz Villarreal J; Walker SA; Tan XNS; Borges C; Wolfram J
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119641. PubMed ID: 37996057
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
Ozawa PMM; Alkhilaiwi F; Cavalli IJ; Malheiros D; de Souza Fonseca Ribeiro EM; Cavalli LR
Breast Cancer Res Treat; 2018 Dec; 172(3):713-723. PubMed ID: 30173296
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy.
Kim MW; Lee H; Lee S; Moon S; Kim Y; Kim JY; Kim SI; Kim JY
BMC Cancer; 2024 Feb; 24(1):185. PubMed ID: 38326737
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles-associated miRNAs in triple-negative breast cancer: from tumor biology to clinical relevance.
Berti FCB; Tofolo MV; Nunes-Souza E; Marchi R; Okano LM; Ruthes M; Rosolen D; Malheiros D; Fonseca AS; Cavalli LR
Life Sci; 2024 Jan; 336():122332. PubMed ID: 38070862
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
14. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
[TBL] [Abstract][Full Text] [Related]
15. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome.
Tkach M; Thalmensi J; Timperi E; Gueguen P; Névo N; Grisard E; Sirven P; Cocozza F; Gouronnec A; Martin-Jaular L; Jouve M; Delisle F; Manel N; Rookhuizen DC; Guerin CL; Soumelis V; Romano E; Segura E; Théry C
Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2107394119. PubMed ID: 35439048
[TBL] [Abstract][Full Text] [Related]
17. Proteomics profiling identifies extracellular vesicles' cargo associated with tumour cell induced platelet aggregation.
McNamee N; de la Fuente LR; Santos-Martinez MJ; O'Driscoll L
BMC Cancer; 2022 Sep; 22(1):1023. PubMed ID: 36171564
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs.
González-Callejo P; Gener P; Díaz-Riascos ZV; Conti S; Cámara-Sánchez P; Riera R; Mancilla S; García-Gabilondo M; Peg V; Arango D; Rosell A; Labernadie A; Trepat X; Albertazzi L; Schwartz S; Seras-Franzoso J; Abasolo I
Int J Cancer; 2023 May; 152(10):2153-2165. PubMed ID: 36705298
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications.
Shimoda A; Miura R; Tateno H; Seo N; Shiku H; Sawada SI; Sasaki Y; Akiyoshi K
Small Methods; 2022 Feb; 6(2):e2100785. PubMed ID: 35174988
[TBL] [Abstract][Full Text] [Related]
20. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
